Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Operating Expenses | 1,460 | 1,790 | 3,120 | 3,250 | 2,160 |
| Operating Income | -1,460 | -1,790 | -3,120 | -3,250 | -2,160 |
| Interest Expense | 0 | 0 | 10 | 30 | 10 |
| Other Income | 40 | 20 | 50 | 120 | 50 |
| Pre-tax Income | -1,420 | -1,770 | -3,080 | -3,160 | -2,120 |
| Net Income Continuous | -1,429 | -1,772 | -3,089 | -3,159 | -2,121 |
| Net Income | $-1,429 | $-1,772 | $-3,089 | $-3,159 | $-2,121 |
| EPS Basic Total Ops | -611.90 | -786.73 | -1,311.20 | -1,311.20 | -1,048.95 |
| EPS Basic Continuous Ops | -595.42 | -770.43 | -1,287.08 | -1,316.25 | -1,060.50 |
| EPS Diluted Total Ops | -611.90 | -786.73 | -1,311.20 | -1,311.20 | -1,048.95 |
| EPS Diluted Continuous Ops | -595.42 | -770.43 | -1,287.08 | -1,316.25 | -1,060.50 |
| EBITDA(a) | $-1,360 | $-1,690 | $-3,020 | $-3,150 | $-2,090 |